Wegovy before and after pics: what the evidence actually shows

What before and after photos can and cannot tell you

The decision many people face is simple to state and hard to navigate: you have seen images online, perhaps on social media or in a news article, and you are trying to work out whether they are trustworthy guides to what Wegovy might do for you. They are not, and not because the results are fake. The problem is selection. Pictures that circulate are chosen for visual impact. They capture people at the upper end of the response range, often after six months or more of treatment alongside genuine lifestyle changes, and they show nothing about what those people weighed to begin with, what else they changed, or whether the image has been edited.

Clinical trial data gives a far more honest picture. The STEP 1 trial, published in the New England Journal of Medicine, followed adults using semaglutide 2.4 mg for 68 weeks alongside a reduced-calorie diet and increased activity. Average body weight fell by around 15%. That is a meaningful result at a population level. But averages conceal a wide distribution: some participants lost considerably more, some lost less, and a small number did not respond well. A photograph of the highest responder, posted without that context, is not a lie, but it is not a useful prediction either.

For a fuller sense of what the published evidence says about Wegovy results (including how the 2.4 mg and the newer 7.2 mg doses compare) the Wegovy results page on this site sets out the trial data without the noise of cherry-picked images.

How Wegovy's timeline actually works, and why early pictures are misleading

One reason before and after images mislead is timing. Wegovy treatment begins at 0.25 mg and is titrated upward by the prescriber over several months before reaching a maintenance dose. The body adjusts to each increase, and meaningful weight loss typically builds across that escalation period rather than arriving in one sudden shift. A photo taken at four weeks, when most people are still on a starter dose, will look very different from one taken at six months at full maintenance dosage.

If you are curious what the first month looks like in practice, the one-month Wegovy experience page covers what most people realistically notice early on, which is often appetite changes before visible weight difference. Visible changes, when they come, tend to track with cumulative weight lost rather than any single dose step. The timeline for how long Wegovy takes to work outlines this progression in more detail.

There is also a biological reason for variability that no photograph captures. People respond differently depending on starting weight, metabolic factors, how well they tolerate each dose, and how consistently they maintain dietary and activity changes alongside treatment. A picture of someone else's six-month result is simply not a prediction of your twelve-week result.

Men's results versus the images you see

The before and after images that dominate social media skew heavily towards women, partly reflecting who is more likely to post publicly about weight and appearance. Men using Wegovy do see meaningful results in clinical data, though the visual presentation of weight loss differs between people depending on where they carry weight and how muscle mass shifts during treatment. The dedicated page on Wegovy results in men looks at what the evidence says for male participants specifically, rather than relying on the curated subset of images available online.

It is worth noting that clinical trials for semaglutide included both men and women, and average results across the STEP programme reflect a mixed population. The NHS provides clear patient-level guidance on semaglutide, including what to expect during treatment, which is a more reliable reference point than any individual photograph.

Our prescribers hear this question regularly: people who have looked at images online and want an honest assessment of what is realistic for their own situation. That is exactly the kind of conversation a clinical consultation is for.

Making the decision: what matters more than the photos

If you are weighing up whether Wegovy is right for you, the photos are the least useful input. The questions that actually matter are whether you meet the licensed eligibility criteria (BMI of 30 or above, or 27 or above with a weight-related condition), whether there are any medical reasons it would not suit you, and what a realistic outcome looks like given your specific circumstances. Those are clinical questions, not aesthetic ones.

For context on what treatment involves practically, the Wegovy overview page covers how it works, the licensed UK dose schedule, and what the NHS and NICE guidance says about access. If cost is part of your decision, the Wegovy prices page sets out what private treatment typically costs in the UK and what a legitimate price includes. Legitimacy matters here: Wegovy is a Prescription-Only Medicine, and any route to it that does not involve a prescriber-led clinical assessment is not a legal or safe one.

At nume, every consultation is read and assessed by a GPhC-registered Independent Prescriber on the same day you submit it. There is no algorithm making the call. If treatment is clinically appropriate, your prescription is issued and your order dispatched the same day, arriving free the next working day in plain packaging. If you are ready to move past the images and get a real clinical view of your options, you can start your free consultation today.